Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TAGO DIFFU-GEN-APOLIPOPROTEIN B-100

K-Number: K833129 · 1983-11-21

ApplicantTago, Inc.
Decision Date1983-11-21
Product CodeMSJ
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

TAGO DIFFU-GEN-APOLIPOPROTEIN B-100 is the device name listed in this FDA 510(k) record. The listed applicant is Tago, Inc.. It received FDA 510(k) clearance on 1983-11-21 under 510(k) number K833129. The device is classified under product code MSJ. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TAGO DIFFU-GEN-APOLIPOPROTEIN B-100?

TAGO DIFFU-GEN-APOLIPOPROTEIN B-100 is a medical device that received FDA 510(k) clearance on 1983-11-21. The listed applicant is Tago, Inc.. The 510(k) number is K833129.

When did TAGO DIFFU-GEN-APOLIPOPROTEIN B-100 receive FDA 510(k) clearance?

TAGO DIFFU-GEN-APOLIPOPROTEIN B-100 received FDA 510(k) clearance on 1983-11-21, under 510(k) number K833129.

Who is the listed applicant for TAGO DIFFU-GEN-APOLIPOPROTEIN B-100?

The FDA 510(k) record lists Tago, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TAGO DIFFU-GEN-APOLIPOPROTEIN B-100?

The FDA product code for TAGO DIFFU-GEN-APOLIPOPROTEIN B-100 is MSJ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Tago, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K841734TAGO FIFFU-GEN, OROSOMUCOIDK841265TAGO DIFFU-GEN C-REACTIVE PROTEINK834218DIFFU-GEN APOLIPOPROTEIN A-I RADIAL -K840404DIFFU-GEN HAPTOGLOBIN RADIAL IMMUNOK830611RA SCREENING TESTK830531MONO SCREENING TEST

View all 8 devices →

Related Devices (Code: MSJ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K072977DIAZYME APOLIPOPROTEIN A-1 ASSAYGeneral AtomicsK073488DIAZYME APOLIPOPROTEIN B ASSAY, MODEL DZXXX-X; B CALIBRATOR, MODEL DZXXXDiazyme LaboratoriesK061377APOLIPOPROTEIN A1 AND APOLIPOPROTEIN B REAGENTS AND CALIBRATORSPointe Scientific, Inc.,K063608DIMENSION VISTA APOA1 AND APOB FLEX REAGENT CARTRIDGES AND PROTEIN 1 CALIBRATOR AND CONTROL MEDIUM AND HIGHDade Behring, Inc.K9926628 ADDITIONAL ASSAYS FOR THE BAYER ADVIA 1650 CHEMISTRY SYSTEMBayer Corp.K970314SYNCHRON LX SYSTEMS APOLIPOPROTEIN (APOA AND APOB) REAGENTSBeckman Instruments, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑